259 related articles for article (PubMed ID: 12134108)
21. Transforming growth factor beta1-modified donor cell transfusion induced allo-heart tolerance.
Cheng J; Xia SS; Xie S; Tang LG; Shi XF
Transplant Proc; 2005 Jun; 37(5):2360-4. PubMed ID: 15964416
[TBL] [Abstract][Full Text] [Related]
22. Gene transfer for transplantation. Prolongation of allograft survival with transforming growth factor-beta 1.
Qin L; Chavin KD; Ding Y; Woodward JE; Favaro JP; Lin J; Bromberg JS
Ann Surg; 1994 Oct; 220(4):508-18; discussion 518-9. PubMed ID: 7944661
[TBL] [Abstract][Full Text] [Related]
23. Immature and mature CD8alpha+ dendritic cells prolong the survival of vascularized heart allografts.
O'Connell PJ; Li W; Wang Z; Specht SM; Logar AJ; Thomson AW
J Immunol; 2002 Jan; 168(1):143-54. PubMed ID: 11751957
[TBL] [Abstract][Full Text] [Related]
24. Generation of cytotoxic T cell against HBcAg using retrovirally transduced dendritic cells.
Ding CL; Yao K; Zhang TT; Zhou F; Xu L; Xu JY
World J Gastroenterol; 2003 Jul; 9(7):1512-5. PubMed ID: 12854153
[TBL] [Abstract][Full Text] [Related]
25. Donor pretreatment with Flt-3 ligand augments antidonor cytotoxic T lymphocyte, natural killer, and lymphokine-activated killer cell activities within liver allografts and alters the pattern of intragraft apoptotic activity.
Qian S; Lu L; Fu F; Li W; Pan F; Steptoe RJ; Chambers FG; Starzl TE; Fung JJ; Thomson AW
Transplantation; 1998 Jun; 65(12):1590-8. PubMed ID: 9665075
[TBL] [Abstract][Full Text] [Related]
26. In vitro propagation and homing of liver-derived dendritic cell progenitors to lymphoid tissues of allogeneic recipients. Implications for the establishment and maintenance of donor cell chimerism following liver transplantation.
Thomson AW; Lu L; Subbotin VM; Li Y; Qian S; Rao AS; Fung JJ; Starzl TE
Transplantation; 1995 Feb; 59(4):544-51. PubMed ID: 7878760
[TBL] [Abstract][Full Text] [Related]
27. Prolongation of cardiac allograft survival by systemic administration of immature recipient dendritic cells deficient in NF-kappaB activity.
Tiao MM; Lu L; Tao R; Wang L; Fung JJ; Qian S
Ann Surg; 2005 Mar; 241(3):497-505. PubMed ID: 15729074
[TBL] [Abstract][Full Text] [Related]
28. Differential effects of exogenous interleukin-10 on cardiac allograft survival: inhibition of rejection by recipient pretreatment reflects impaired host accessory cell function.
Li W; Fu F; Lu L; Narula SK; Fung JJ; Thomson AW; Qian S
Transplantation; 1999 Nov; 68(9):1402-9. PubMed ID: 10573082
[TBL] [Abstract][Full Text] [Related]
29. Cross-tolerance of recipient-derived transforming growth factor-beta dendritic cells.
Tiao MM; Lu L; Huang LT; Liang CD; Chen CL; Tao R; Fung JJ; Qian S
Transplant Proc; 2007; 39(1):281-2. PubMed ID: 17275522
[TBL] [Abstract][Full Text] [Related]
30. Systemic administration of anti-interleukin-10 antibody prolongs organ allograft survival in normal and presensitized recipients.
Li W; Fu F; Lu L; Narula SK; Fung JJ; Thomson AW; Qian S
Transplantation; 1998 Dec; 66(12):1587-96. PubMed ID: 9884244
[TBL] [Abstract][Full Text] [Related]
31. TGF-beta1 and donor dendritic cells are common key components in donor-specific blood transfusion and anti-class II heart graft enhancement, whereas tolerance induction also required inflammatory cytokines down-regulation.
Gagne K; Brouard S; Guillet M; Cuturi MC; Soulillou JP
Eur J Immunol; 2001 Oct; 31(10):3111-20. PubMed ID: 11592088
[TBL] [Abstract][Full Text] [Related]
32. Alloantigen presentation by ethylcarbodiimide-treated dendritic cells induces T cell hyporesponsiveness, and prolongs organ graft survival.
Kaneko K; Morelli AE; Wang Z; Thomson AW
Clin Immunol; 2003 Sep; 108(3):190-8. PubMed ID: 14499242
[TBL] [Abstract][Full Text] [Related]
33. Plasmacytoid dendritic cell precursors induce allogeneic T-cell hyporesponsiveness and prolong heart graft survival.
Abe M; Wang Z; de Creus A; Thomson AW
Am J Transplant; 2005 Aug; 5(8):1808-19. PubMed ID: 15996227
[TBL] [Abstract][Full Text] [Related]
34. Dendritic cells genetically engineered to express IL-4 exhibit enhanced IL-12p70 production in response to CD40 ligation and accelerate organ allograft rejection.
Kaneko K; Wang Z; Kim SH; Morelli AE; Robbins PD; Thomson AW
Gene Ther; 2003 Jan; 10(2):143-52. PubMed ID: 12571643
[TBL] [Abstract][Full Text] [Related]
35. Bone marrow-derived immature dendritic cells prime in vivo alloreactive T cells for interleukin-4-dependent rejection of major histocompatibility complex class II antigen-disparate cardiac allograft.
Buonocore S; Flamand V; Goldman M; Braun MY
Transplantation; 2003 Feb; 75(3):407-13. PubMed ID: 12589166
[TBL] [Abstract][Full Text] [Related]
36. Growth of donor-derived dendritic cells from the bone marrow of murine liver allograft recipients in response to granulocyte/macrophage colony-stimulating factor.
Lu L; Rudert WA; Qian S; McCaslin D; Fu F; Rao AS; Trucco M; Fung JJ; Starzl TE; Thomson AW
J Exp Med; 1995 Aug; 182(2):379-87. PubMed ID: 7629500
[TBL] [Abstract][Full Text] [Related]
37. Mechanistic insights into impaired dendritic cell function by rapamycin: inhibition of Jak2/Stat4 signaling pathway.
Chiang PH; Wang L; Bonham CA; Liang X; Fung JJ; Lu L; Qian S
J Immunol; 2004 Feb; 172(3):1355-63. PubMed ID: 14734710
[TBL] [Abstract][Full Text] [Related]
38. Heart, but not skin, allografts from donors lacking Flt3 ligand exhibit markedly prolonged survival time.
Wang Z; Castellaneta A; De Creus A; Shufesky WJ; Morelli AE; Thomson AW
J Immunol; 2004 May; 172(10):5924-30. PubMed ID: 15128773
[TBL] [Abstract][Full Text] [Related]
39. Gene transfer of transforming growth factor-beta 1 prolongs murine cardiac allograft survival by inhibiting cell-mediated immunity.
Qin L; Ding Y; Bromberg JS
Hum Gene Ther; 1996 Oct; 7(16):1981-8. PubMed ID: 8930658
[TBL] [Abstract][Full Text] [Related]
40. Effects of liver-derived dendritic cell progenitors on Th1- and Th2-like cytokine responses in vitro and in vivo.
Khanna A; Morelli AE; Zhong C; Takayama T; Lu L; Thomson AW
J Immunol; 2000 Feb; 164(3):1346-54. PubMed ID: 10640749
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
